AKEBIA THERAPEUTICS INC (AKBA)
US00972D1054 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 41.96M | 42.92M | 90.50M | 149.80M | 228.70M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 40.00M | |||
| Receivables | 26.62M | 39.29M | 40.30M | 51.60M | 26.90M | |||
| Inventories | 25.53M | 15.69M | 21.60M | 36.60M | 61.00M | |||
| Other Current Assets | 18.83M | 20.24M | 32.90M | 33.10M | 14.90M | |||
| Total Current Assets | 112.94M | 118.15M | 185.20M | 271.10M | 371.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.66M | 16.05M | 34.40M | 40.60M | 35.50M | |||
| Goodwill | 59.04M | 59.04M | 59.00M | 59.00M | 55.10M | |||
| Intangibles | 27.03M | 36.04M | 72.10M | 108.10M | 144.20M | |||
| Other Non-Current Assets | 11.79M | 12.42M | 5.40M | 50.40M | 38.00M | |||
| Total Non-Current Assets | 112.53M | 123.55M | 170.90M | 258.20M | 272.70M | |||
| TOTAL ASSETS | 225.48M | 241.70M | 356.10M | 529.30M | 644.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 17.50M | 32.00M | 97.50M | N/A | |||
| Accrued Expenses | 53.91M | 67.73M | 75.80M | 109.00M | 130.60M | |||
| Accounts Payable | 11.88M | 14.63M | 18.00M | 33.60M | 41.30M | |||
| Other Current Liabilities | 695.00K | 0.00 | 3.70M | 20.90M | 15.20M | |||
| Total Current Liabilities | 66.49M | 99.87M | 129.50M | 261.10M | 187.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 30.14M | 17.18M | 34.10M | 0.00 | 96.40M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 156.10M | 155.23M | 187.20M | 194.30M | 113.00M | |||
| Total Non-Current Liabilities | 186.25M | 172.42M | 221.30M | 194.20M | 209.40M | |||
| TOTAL LIABILITIES | 252.74M | 272.29M | 350.80M | 455.30M | 396.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.63B | -1.61B | -1.56B | -1.46B | -1.18B | |||
| Additional Paid In Capital | 1.60B | 1.58B | 1.56B | 1.54B | 1.43B | |||
| Common Shares | 2.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 6.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 209.45M | 194.58M | 184.10M | 177.00M | 148.10M | |||
| Tangible Book Value per Share | -0.54 | -0.65 | -0.68 | -0.53 | 0.33 | |||
| Total Shareholders' Equity | -27.26M | -30.58M | 5.20M | 74.00M | 247.60M | |||
| TOTAL LIABILITIES AND EQUITY | 225.48M | 241.70M | 356.10M | 529.30M | 644.10M | |||
| Statistics | ||||||||
| Debt/Equity | -1.11 | -0.56 | 6.56 | N/A | 0.39 | |||
| Current Ratio | 1.70 | 1.18 | 1.43 | 1.04 | 1.99 | |||
| Return On Assets (ROA) | -19.10% | -21.48% | -26.45% | -53.28% | -59.74% | |||
| Return On Equity (ROE) | N/A | N/A | -1811.54% | -381.08% | -155.41% | |||
All data in USD